<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="31927" end="31932" sStart="31903" offset="24" sid="r7.1.use.v.0325" wn="1" wnkey="use%2:34:01::" text="This is accomplished by using an &quot;anchor gate&quot; which is sufficiently high." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-10.anc" start="36046" end="36057" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="After cDNA amplification, 25 ul of PCR mix was removed and &lt;b&gt;transferred&lt;/b&gt; to a microcenterfuge tube." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="19090" end="19096" sStart="null" offset="64" sid="r7.serve.v.0169" wn="1" wnkey="serve%2:42:03::" text="Perhaps in the aged cell as well, the CD28 -memory cell serves a similar protective role against a variety of viruses." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="21002" end="21007" sStart="null" offset="47" sid="r7.serve.v.0180" wn="1" wnkey="serve%2:42:03::" text="The data argue that the CD28 -cell may serve as a natural endpoint in the differentiation of CD8 +cells, as proposed by Effros et al [ 27 ] , where aging represents a &quot;normal endpoint&quot; that occurs after many years of immune activity, while AIDS represents an accelerated endpoint due to the increase rate in T cell formation during attempted compensation for CD4 +loss induced by HIV." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="25818" end="25829" sStart="null" offset="136" sid="r11.recommend.v.0404" wn="1" wnkey="recommend%2:32:01::" text="3 years) used in this study had a CD4 +T cell count from 210-500 cells/mm 3and fell in the A2 and B2 classification recommended by the Centers for Disease Control." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="38381" end="38392" sStart="null" offset="30" sid="r11.recommend.v.0405" wn="1" wnkey="recommend%2:32:01::" text="The procedure was followed as recommended by the manufacturer." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="11681" end="11687" sStart="null" offset="121" sid="r9.normal.j.0673" wn="1" wnkey="normal%3:00:01::" text="Only in the case of 11-2 was an appreciable number of cytokine-producing cells observed [ 25 ] . For normal young cells at least 15-30% of CD4 +cells were positive for 11-2 while only 3-6% of the CD8 +cells were positive." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="11259" end="11265" sStart="null" offset="163" sid="r9.normal.j.0489" wn="1" wnkey="normal%3:00:01::" text="2. It is evident that the cells from the HIV +and aged states have a greater capacity for TNF-? and IFN-? production compared to the normal control CD28 -or CD28 +population." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="33449" end="33455" sStart="null" offset="101" sid="r9.normal.j.0469" wn="1" wnkey="normal%3:00:01::" text="1. In our experience, the CD3 +CD4 +comprise 95% or more of the CD3 +CD8 -T cell subset in normal blood." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="8193" end="8199" sStart="null" offset="114" sid="r9.normal.j.0691" wn="3" wnkey="normal%3:00:03::" text="The CD4 +T cells from HIV +donors also are slightly more capable of TNF-? production than the normal CD4 +T cells (51." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="21147" end="21153" sStart="null" offset="197" sid="r9.normal.j.0192" wn="1" wnkey="normal%3:00:01::" text="The data argue that the CD28 -cell may serve as a natural endpoint in the differentiation of CD8 +cells, as proposed by Effros et al [ 27 ] , where aging represents a &quot;normal endpoint&quot; that occurs after many years of immune activity, while AIDS represents an accelerated endpoint due to the increase rate in T cell formation during attempted compensation for CD4 +loss induced by HIV." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="10625" end="10631" sStart="null" offset="102" sid="r9.normal.j.0914" wn="2" wnkey="normal%3:00:02::" text="In these states, the percent of CD28 -cells producing each cytokine dominates the normal young controls by a 2:1 to 3:1 margin." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="1933" end="1939" sStart="null" offset="88" sid="r9.normal.j.0246" wn="2" wnkey="normal%3:00:02::" text="Similarly, with TNF-?, there are contradictory reports of decreased [ 37 38 ] , normal [ 29 ] , or increased [ 12 31 39 40 ] production in the HIV +and aged T cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="15409" end="15415" sStart="null" offset="66" sid="r9.level.n.0194" wn="1" wnkey="level%1:07:00::" text="The question resolves into two parts: are TNF-? and IFN-? levels increased in the HIV +and aged states, and do the CD8 +T cells show increased production of these cytokines." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="29497" end="29505" sStart="null" offset="147" sid="r11.function.n.0391" wn="2" wnkey="function%1:07:00::" text="5 ng/ml) as described previously [ 25 ] . Either monensin (1 uM) or brefeldin A (1 ug/ml) was used in all cases to block Golgi function and allow cytokine accumulation with the cell." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="7692" end="7696" sStart="null" offset="73" sid="r9.fold.v.0893" wn="2147483645" wnkey="null" text="Aged CD8 +T cells show a significant increase (approximately 3 fold) over young cells in the percentage producing TNF-? (57." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="12923" end="12927" sStart="null" offset="82" sid="r9.fold.v.0853" wn="2147483645" wnkey="null" text="For IFN-?, CD8 +T cells from both the HIV +and aged states show a 4.5-5 fold enhancement in cDNA copies (32,000 and 47,000 respectively versus controls of 7,400 and 9,100)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="13719" end="13723" sStart="null" offset="131" sid="r9.fold.v.0239" wn="2147483645" wnkey="null" text="The results, shown in Table III, demonstrate that production of IFN-? is upregulated over controls, from 3.5-4 fold, for the CD8 +T cells from HIV +and aged donors." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="7889" end="7893" sStart="null" offset="99" sid="r9.fold.v.0732" wn="2147483645" wnkey="null" text="In the HIV +cases also, the CD8 +T cells show significantly enhanced TNF-? production (2 fold)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="13115" end="13119" sStart="null" offset="71" sid="r9.fold.v.0198" wn="" wnkey="null" text="Likewise, the TNF-? cDNA copies are enhanced approximately 4 fold in the CD8 +T cells from aged and HIV +states." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="28548" end="28555" sStart="null" offset="13" sid="r10.control.n.0693" wn="4" wnkey="control%1:09:02::" text="The yield of control and aged cells varied from 58-89% generally, whereas the yield from HIV +blood generally fell between 24-68%." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="4694" end="4702" sStart="null" offset="0" sid="r10.control.n.0137" wn="4" wnkey="control%1:09:02::" text="Controls (not shown) for every sample were also examined for cytokine-producing cells (upper quadrants) in which no activators were added; 0.0-0." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="8913" end="8921" sStart="null" offset="5" sid="r10.control.n.0735" wn="4" wnkey="control%1:09:02::" text="Such controls showed no significant cytokine-containing cells, and these samples were used to calculate the resting CD4 +/CD8 +distribution and the CD28 +/CD28 -distribution." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="12573" end="12581" sStart="null" offset="75" sid="r10.control.n.0572" wn="4" wnkey="control%1:09:02::" text="The mRNA isolated from CD8 +T cells from 12 aged, 10 HIV +and 15 controls were purified and used in these studies." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="13503" end="13510" sStart="null" offset="73" sid="r10.control.n.0358" wn="4" wnkey="control%1:09:02::" text="The PBMC and purified CD8 +T cells from eight donors and seven control donors were incubated for 66 hrs, and the media examined by ELISA." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="25514" end="25519" sStart="null" offset="62" sid="r10.board.n.0460" wn="1" wnkey="board%1:14:00::" text="This study was approved by the Institutional Review Board of the Ponce School of Medicine, Ponce, PR." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="1229" end="1236" sStart="null" offset="268" sid="r9.appear.v.0764" wn="1" wnkey="appear%2:39:00::" text="There is a relative increase in the memory cell repertoire [ 17 18 19 20 ] , and an increase in absolute counts in the CD8 +CD28 -populations in both aged [ 22 ] and HIV +donors [ 22 23 24 25 ] . The CD8 +CD28 -T cell in the HIV +state appears to be the major cytotoxic T cell (CTL) [ 26 ] , but curiously, has shortened telemer lengths as well [ 27 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-10.anc" start="36154" end="36159" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="The same volume of denaturation solution (alkaline pH) was &lt;b&gt;added&lt;/b&gt; to the tube and incubated for 10 min at room temperature." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-10.anc" start="36941" end="36946" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="The wells were washed again, and 100 ul of stabilized chromogen (substrate) was &lt;b&gt;added&lt;/b&gt;." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="28845" end="28852" sStart="null" offset="159" sid="r11.absence.n.0407" wn="1" wnkey="absence%1:26:00::" text="Accessory cells were effectively removed during T cell isolation as shown by the failure of mitogen-induced proliferation in the absence of coactivators." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-10.anc" start="8809" end="8816" sStart="null" offset="110" sid="r11.absence.n.0212" wn="1" wnkey="absence%1:26:00::" text="For each blood sample, a non-activated control was prepared in which the PBMC were incubated in the absence of activators (anti-CD3 and PMA), and then examined by flow cytometry." />
  </sentences>
</list>